Sentences with phrase «generic drug prices»

Although increases in generic drug prices are thought to be the result of insufficient competition, no study has examined this relationship.

Recent generic drug price increases have made us concerned and caused us to take positive action to address an opportunity to help a needy patient population.

However analysts point to a bounce in Teva's shares over the past four months and a slowing in the rate of decline of U.S. generic drug prices as bright spots.

Acquiring Akorn would add around $ 1 billion in annual sales to Fresenius» drugmaking division, giving it a significantly larger presence in eyecare and other areas widely perceived as somewhat insulated from generic drug pricing pressure.

Mylan No. 2 targeted in massive generic drug price collusion probe.

Generic drug giant Mylan is cutting its financial outlook as it continues to face pressure from falling generic drug prices (a fate that similarly struck rival Teva Pharmaceuticals).

This was a great value buy a few years ago when provincial governments were pressuring the chain to lower generic drug prices.

In August, two members of Congress investigating generic drug price increases wrote to Valeant Pharmaceuticals after that company acquired two heart drugs, Isuprel and Nitropress, from Marathon Pharmaceuticals and promptly raised their prices by 525 percent and 212 percent respectively.

Decreased market competition causes generic drug prices to rise significantly, according to an article published in Annals of Internal Medicine.

[11] In order to stop this inflationary effect on generic drug prices, in 2006, the Ontario Drug Benefit Act, the Drug Interchangeability and Dispensing Fee Act, and the Regulations under them were amended to prohibit rebates.

Since last August, the world's biggest generics drugmaker has seen its share price fall over 40 percent due to a decline in U.S. generic drug prices and copycat competition for its blockbuster multiple sclerosis drug Copaxone.

Profit declines sharply and company cuts full - year outlook

Cardinal Health Inc. reported a sharp decline in profit in its last quarter and lowered its full - year outlook following inventory write - downs in its overseas businesses and a sharper - than - anticipated decline in generic drug prices.

«Generic drug prices increase when market competition decreases.»

The U.S. filed its first charges in a generic drug price - fixing probe on Wednesday, according to a report.

Another bright spot could be the slowing in the decline of U.S. generic drug prices, according to report from Credit Suisse, citing data from health information company IQVIA.

Standing Committee on Health proposes National Pharmacare program, modifications to prescription and generic drug pricing

Investigators studied prescription drug claims from commercial health plans between 2008 and 2013 to determine the association between market competition levels and changes in generic drug prices.

Standing Committee on Health proposes National Pharmacare program, modifications to prescription and generic drug pricing